Drug Accountability And Returns Management

eClinical technologies are becoming more commonplace in drug development as biopharma adopts validated methods to maintain compliance; patient recruitment, engagement, and safety; and supply chain forecasting. A growing number of sponsors are adopting a proven electronic technology: Electronic Drug Accountability and Returns Management, or DARM.

This white paper illustrates how sponsors are using electronic solutions for Drug Accountability (DA), because they recognize the significant increase in efficiency and accuracy that these methods provide.